Back
Open Access

Risk of immune targeting of cardiovascular disease - What is acceptable?

Session: Targeting inflammation in cardiovascular disease - Is it feasible? And safe?
Topic: Pharmacology and Pharmacotherapy
Speaker: Professor W. Koenig (Munich, DE)
Event: ESC CONGRESS 2019

Congress Session

0

About the speaker

Professor Wolfgang Koenig

German Heart Center of Munich,, Munich (Germany)
20 presentations
0 follower

3 more presentations in this session

Non-pharmacological targeting of chronic inflammation and prevention of cardiovascular disease.

Speaker: Professor T. Guzik (Glasgow, UK and Krakow, PL, GB)

Access
Slides
Video
0
Thumbnail

Looking beyond CANTOS - Where will immune targeting bring us?

Speaker: Doctor P. Ridker (Boston, US)

Access
Slides
Video
0
Thumbnail

Precision medicine and cardiovascular immune targeted therapies.

Speaker: Professor G. Hansson (Stockholm, SE)

Access
Slides
Video
0
Thumbnail

Access the full session

Targeting inflammation in cardiovascular disease - Is it feasible? And safe?

Speakers: Professor W. Koenig, Professor T. Guzik, Doctor P. Ridker, Professor G. Hansson
Access
0
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

This platform is supported by

logo Novo Nordisk